Michael A. Crone, Miles Priestman, Marta Ciechonska, Kirsten Jensen, David J. Sharp, Arthi Anand, Paul Randell, Marko Storch & Paul S. Freemont A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics | Nature Communications
AuthorKaren Thurley
London Biofoundry testing and pooling projects
In early 2020, due to reagent and labware shortages, there were significant limitations on SARS-CoV-2 testing capacity worldwide, with the UK’s diagnostic capacity at only 10 000 tests per day at the beginning of April. The London Biofoundry worked together with NHS colleagues to successfully increase testing capacity in accredited NHS laboratories at the St